T1	disease_or_phenotypic_feature 0 23	Glioblastoma multiforme
T2	chemical 64 68	drug
T3	chemical 86 98	Ellagic acid
T4	chemical 128 137	inhibitor
T5	disease_or_phenotypic_feature 280 283	per
T6	disease_or_phenotypic_feature 559 565	cancer
T7	chemical 589 595	oxygen
T8	chemical 617 621	acid
T9	disease_or_phenotypic_feature 659 678	prostatic carcinoma
T10	disease_or_phenotypic_feature 717 724	obesity
T11	chemical 730 738	orlistat
T12	chemical 762 766	drug
T13	chemical 767 777	lorcaserin
T14	chemical 792 803	biochemical
T15	disease_or_phenotypic_feature 829 836	obesity
T16	disease_or_phenotypic_feature 841 848	obesity
T17	disease_or_phenotypic_feature 894 918	congestive heart failure
T18	disease_or_phenotypic_feature 920 923	CHF
T19	chemical 939 945	oxygen
T20	chemical 975 985	Fluoxetine
T21	disease_or_phenotypic_feature 990 998	seizures
T22	chemical 1006 1015	antigenic
T23	disease_or_phenotypic_feature 1016 1024	glaucoma
T24	disease_or_phenotypic_feature 1049 1057	cataract
T25	chemical 1067 1074	Calcium
T26	chemical 1095 1102	mineral
T27	disease_or_phenotypic_feature 1152 1159	obesity
T28	chemical 1170 1174	drug
T29	disease_or_phenotypic_feature 1188 1195	obesity
T30	chemical 1207 1221	growth hormone
T31	disease_or_phenotypic_feature 1232 1241	pituitary
T32	chemical 1306 1310	acid
T33	chemical 1351 1362	doxorubicin
T34	chemical 1404 1408	drug
T35	disease_or_phenotypic_feature 1429 1435	cancer
T36	chemical 1477 1488	biochemical
T37	disease_or_phenotypic_feature 1522 1533	hypokalemia
T38	chemical 1570 1580	creatinine
T39	disease_or_phenotypic_feature 1622 1637	prostate cancer
T40	chemical 1655 1662	antigen
T41	disease_or_phenotypic_feature 1711 1725	prostate tumor
T42	chemical 1726 1734	antigens
T43	chemical 1770 1778	antigens
T44	chemical 1841 1850	magnesium
T45	disease_or_phenotypic_feature 1911 1923	hypocalcemia
T46	disease_or_phenotypic_feature 1925 1936	hypokalemia
T47	disease_or_phenotypic_feature 1942 1958	hypophosphatemia
T48	chemical 1966 1976	anesthesia
T49	disease_or_phenotypic_feature 2001 2009	cataract
T50	chemical 2038 2042	camp
T51	chemical 2044 2063	receptor antagonist
T52	chemical 2065 2073	bosentan
T53	disease_or_phenotypic_feature 2156 2162	facial
T54	disease_or_phenotypic_feature 2163 2169	cancer
T55	disease_or_phenotypic_feature 2170 2174	pain
T56	chemical 2209 2214	MART1
T57	chemical 2215 2222	epitope
T58	disease_or_phenotypic_feature 2236 2244	melanoma
T59	missed_disease_or_phenotypic_feature 141 146	tumor
R1	treats Arg1:T3 Arg2:T59	
R2	treats Arg1:T11 Arg2:T10	
R3	treats Arg1:T13 Arg2:T10	
T60	corrected_disease_or_phenotypic_feature 1232 1249	pituitary tumours
T61	missed_disease_or_phenotypic_feature 1508 1520	hyponatremia
T62	missed_disease_or_phenotypic_feature 1535 1548	hypochloremia
T63	corrected_disease_or_phenotypic_feature 2156 2175	facial cancer pain.
R9	treats Arg1:T52 Arg2:T63	
T64	DONE 2297 2301	DONE
T65	corrected_chemical 1341 1362	PEGylated doxorubicin
R4	treats Arg1:T65 Arg2:T35	
T66	missed_disease_or_phenotypic_feature 2114 2137	evoked hypersensitivity
R5	treats Arg1:T52 Arg2:T66	
